Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia

Neuropsychopharmacology

Volumn 9, Issue 1, 1993, Pages 67-75

  Lipska, Barbara K ^a   Jaskiw, George E ^a,b   Weinberger, Daniel R ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Animal model; Dopamine; Hippocampus; Ibotenic acid; Locomotor activity; Neonatal lesion; Schizophrenia

Indexed keywords

AMPHETAMINE; DOPAMINE; HALOPERIDOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; FEMALE; HIPPOCAMPUS; HYPERACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA; STRESS;

ANIMAL; ANIMALS, NEWBORN; DEXTROAMPHETAMINE; DISEASE MODELS, ANIMAL; FEMALE; HALOPERIDOL; HIPPOCAMPUS; IBOTENIC ACID; MOTOR ACTIVITY; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; STRESS, PSYCHOLOGICAL; SWIMMING;

EID: 0027297279     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.1993.44     Document Type: Article

References (61)

1. Baker DEJ (1989): Reproduction and breeding. In Baker JH, Lindsey JR, Weisbroth SH (eds), The Laboratory Rat. New York, Academic Press, p 154-168
2. Berman KF, Weinberger DR (1991): Functional localization in the brain in schizophrenia. Am Psychiatr Press Rev Psychiatry 10:24-59
3. Bogerts B, Meertz E, Schonfeldt-Bausch R (1985): Basal ganglia and limbic system pathology in schizophrenia. Arch Gen Psychiatry 42:784-791
4. Borison RL, Havdala HS, Diamond BI (1977): Chronic phenyethylamine stereotypy in rats: A new animal model for schizophrenia? Life Sci 21:117-122
5. Brose N, O'Neill RD, Boutelle MG, Anderson SMP, Fillenz M (1987): Effects of an anxiogenic benzodiazepine receptor ligand on motor activity and dopamine release in nucleus accumbens and striatum in the rat. J Neurosci 7:2917-2926
6. Buchsbaum MS, Ingvar DH, Kessler R (1982): Cerebral glucog-raphy with positron tomography. Arch Gen Psychiatry 39:251-259
7. Costall B, Naylor RL (1976): A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride, and metoclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic system. Eur J Pharmacol 40:9-18
8. Crow TJ (1990): Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizopr Bull 16:433-443
9. Csernansky JG, Kerr S, Pruthi R, Prosser ES (1988): Mesolimbic dopamine receptor increases two weeks following hippocampal kindling. Brain Res 449:357-360
10. Davis KL, Kahn RS, Ko G, Davidson M (1991): Dopamine in schizophrenia: A review and reconceptualization. Am J Psychiatry 148:1474-1486
11. Deutch AY Roth (1990): The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res 85:367-403
12. Deutch AY, Clark WA Roth (1990): Prefrontal corticaldepletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res 521:311-315
13. Erinoff L, Snodgrass SR (1986): Effects of adult and neonatal treatment with 6-hydroxydopamine or 5, 7-dihydroxy-tryptamine on locomotor activity, monoamine levels and response to caffeine. Pharmacol Biochem Behav 24:1039-1045
14. Ferino F, Thierry AM, Glowinski J (1987): Anatomical and neurophysiological evidence for a direct projection from Ammon's horn to the medial prefrontal cortex in the rat. Exp Brain Res 65:421-426
15. Fish B, Marcus J, Hans SL, Auerbach JG, Perdue S (1992): Infants at risk for schizophrenia: A sequelae of a genetic neurointegrative defect. A review and replication analysis of pandysmaturation in the Jerusalem Infant Development Study. Arch Gen Psychiatry 49:221-235
16. Freed WJ (1989): An hypothesis regarding the antipsychotic effect of neuroleptic drugs. Pharmacol Biochem Behav 32:337-345
17. Goldberg TE, Gold JM, Braff DL (1991): Neuropsychological functioning and time-linked information processing in schizophrenia. Am Psychiatr Press Rev Psychiatry 10:60-78
18. Goldman-Rakic PS, Selemon LD, Schwartz ML (1984): Dual pathways connecting the dorsolateral prefrontal cortex with the hippocampal formation and parahippocampal cortex in the rhesus monkey. Neuroscience 12:719-743
19. Grace AA (1991): Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia. Neuroscience 41:1-24
20. Groenewegen HJ, Vermeulen-Van der Zee E, Te Kortschot A Witter (1987): Organization of the projections from the subiculum to the ventral striatum in the rat. A study using anterograde transport of phaseolus vulgaris leu-coagglutinin. Neuroscience 23:103-120
21. Hyde T, Casanova M, Kleinman JE, Weinberger DR (1991): Neuroanatomical and neurochemical pathology in schizophrenia. Am Psychiatr Press Rev Psychiatry 10:7-23
22. Jahromi SS, Niesen C, Carlen PL (1991): Amphetamine actions on pre-and postpubertal rat hippocampal dentate granule neurons. Brain Res 556:33-43
23. Jakob H, Beckmann H (1986): Prenatal development disturbances in the limbic allocortex in schizophrenics. J Neural Transm 65:303-326
24. Jaskiw GE, Weinberger DR (1990): Ibotenic acid lesions of the medial prefrontal cortex potentiate FG-7142-induced attenuation of exploratory activity in the rat. Pharmacd Biochem Behav 36:695-697
25. Jaskiw GE, Weinberger DR (1992a): Ibotenic acid lesions of medial prefrontal cortex augment swim-stress-induced locomotion. Pharmacol Biochem Behav 41:607-609
26. Jaskiw GE, Weinberger DR (1992b): Dopamine and schizophrenia -a cortically corrective perspective. Semin Neu-rosci 4:179-188
27. Jaskiw GE, Karoum F, Freed WJ, Phillips I, Kleinman JE, Weinberger DR (1990a): Effect of ibotenic acid lesions of the medial prefrontal cortex on amphetamine-induced locomotion and regional brain catecholamine concentrations in the rat. Brain Res 534:263-272
28. Jaskiw GE, Karoum F, Weinberger DR (1990b): Persistent elevations in dopamine and its metabolites in the nucleus accumbens after mild subchronic stress in rats with ibo-tenic acid lesions of the medial prefrontal cortex. Brain Res 53:321-323
29. Jay T, Witter MP (1991): Distribution of hippocampal CA1 and subicular efferents in the prefrontal cortex of the rat studied by means of anterograde transport of phaseolus vulgaris-leucoagglutinin. J Comp Neurol 313:574-586
30. Juraska JM (1991): Sex differences in "cognitive" regions of the rat brain. Psychoneuroendocrinology 16:105-120
31. Kalsbeek A, Voorn P, Buijs Pool CW, Vylings HBM (1988): Development of the dopaminergic innervation in the prefrontal cortex of the rat. J Comp NeuroI269:56-72
32. Kelley AE, Domesick VB (1982): The distribution of the projection from the hippocampal formation to the nucleus ac-cumbens in the rat: An anterograde and retrograde horseradish peroxidase study. Neuroscience 7:2321-2335
33. Kennard MA (1936): Age and other factors in motor recovery from precentral lesion in monkeys. Am J Physiol 115:138-146
34. Kokkinidis L, Anisman H (1980): Amphetamine models of paranoid schizophrenia: An overview and elaboration of animal experimentation. Psychol Bull 88:551-579
35. Kolb B, Whishaw IQ (1989): Plasticity in the neocortex: Mechanisms underlying recovery from early brain damage. Prog Neurobiol 32:235-276
36. Kolb B, Gibb R (1991): Sparing of function after neonatal frontal lesions correlates with increased cortical dendritic branching: A possible mechanism for the Kennard effect. Behav Brain Res 43:51-56
37. Kornetsky C, Markowitz R (1978): Animal models of schizophrenia. In Lipton MA, DiMascio A, Killan KF (eds), Psychopharmacology: A Generation of Progress. New York, Raven Press, pp 583-593
38. Lanier LP, Isaacson RL (1977): Early developmental changes in the locomotor response to amphetamine and their relation to hippocampal formation. Brain Res 126:567-575
39. LeMoal M, Simon H (1991): Mesocorticolombic dopaminergic network: Functional and regulatory roles. Physiol Rev 71:155-234
40. Lipska BK, Jaskiw GE, Chrapusta S, Karoum F, Weinberger DR (1992): Ibotenic acid lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Res 585:1-6
41. McKinney WT, Moran EC (1981): Animal models of schizophrenia. Am J Psychiatry 138:478-483
42. Mogenson GJ, Nielsen MAA (1984): A study of the contribution of hippocampal-accumbens-subpallidal projections to locomotor activity. Behav Neural Biol 42:38-51
43. Mogenson GJ, Wu M (1991): Effects of atration of dopamine D2 agonist quinpirole on exploratory locomotion. Brain Res 551:216-220
44. Pearson DE, Teicher MH, Shaywitz BA, Cohen DJ, Young JG, Anderson GM (1980): Environmental influences on body weight and behavior in developing rats after neo-nataI6-hydroxydopamine. Science 209:715-717
45. Piazza PR, Deminiere JM, Lemoai M, Simon H (1989): Factors thatpredict individual vulnerability to amphetamine self-administration. Science 245:1511-1513
46. Piazza PV, Rouge-Pont F, Derniniere JM, Kharoubi M, LeMoal M, Simon H (1991): Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accum-bens of rats predisposed to develop amphetamine selfadministration. Brain Res 567:169-174
47. Pickar D (1988): Perspectives on a time-dependent model of neuroleptic action. Schizophr Bull 14:255-268
48. Pickar D, Brier A, Hsiao JK (1990): CSF and plasma monoamine metabolites and their relation to psychosis: Implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry 47:641-648
49. Pijenburg AJJ, Honig WMM, Van Rossum JM (1975): Inhibition of d-amphetamine induced locomotor activity by injection of haloperidol into nucleus accumbens of the rat. Psychopharmacologia 41:87-95
50. Pycock CJ, Kerwin RW, Carter CJ (1980): Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 286:74-77
51. Remington R, Anisman H (1976): Genetic and ontogenic variations in locomotor activity following treatment with scopolamine and d-amphetamine. Dev Psychobiol 9: 579-585
52. Rupniak MJ, Hall MD, Kelly E, Fleminger S, Kilpatrick G, Jenner P, Marsden CD (1985): Mesolimbic dopamine function is not altered during continuous chronic treatment of rats with typical and atypical neuroleptic drugs. J Neural Transm 62:249-266
53. Saji M, Reis DJ (1987): Delayed transneuronal death of substantia nigra neurons prevented by gma-aminobutyric acid antagonist. Science 235:66-69.
54. Sesack SR, Pickel VM (1990): In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in apposition to each other. Brain Res 527:266-271
55. Sharp T, Zetterstrom T, Ungerstedt U (1987): A direct comparison of amphetamine-induced behaviors and regional brain dopamine release in the rat using intracerebral microdialysis. Brain Res 401:322-330
56. Stevens JR (1992): Abnormal reinnervation as a basis for schizophrenia: A hypothesis. Arch Gen Psychiatry 49: 238-243
57. Tsuang MT, Simpson JC (1988): Nosology, epidemiology and genetics of schizophrenia. In Nasrallah HA (ed), Handbook of Schizophrenia, Vol. 3. New York, Elsevier
58. Weinberger DR (1987): Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
59. Weinberger DR, Berman KF, Zec RF (1986): Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. I: Regional cerebral blood flow (rCBF) evidence. Arch Gen Psychiatry 43:114-125
60. Weinberger DR, Berman KF, Illowsky B (1988): Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III: A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 45: 609-615
61. Yang CR, Mogenson GJ (1985): An electrophysiological study of the neural projections from the hippocampus to the ventral pallidum and the subpallidal areas by way of the nucleus accumbens. Neuroscience 15:1015-1024